TC BioPharm (Holdings) PLC (TCBP)
1.46
+0.01
(+0.69%)
USD |
NASDAQ |
May 03, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
TC BioPharm Enterprise Value: 1.528M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.528M |
| May 02, 2024 | 1.496M |
| May 01, 2024 | 1.592M |
| April 30, 2024 | 1.432M |
| April 29, 2024 | 1.624M |
| April 26, 2024 | 1.751M |
| April 25, 2024 | 1.879M |
| April 24, 2024 | 1.560M |
| April 23, 2024 | 1.911M |
| April 22, 2024 | 1.911M |
| April 19, 2024 | 1.588M |
| April 18, 2024 | 1.400M |
| April 17, 2024 | 1.176M |
| April 16, 2024 | 1.112M |
| April 15, 2024 | 1.048M |
| April 12, 2024 | 2.007M |
| April 11, 2024 | 2.390M |
| April 10, 2024 | 2.295M |
| April 09, 2024 | 2.806M |
| April 08, 2024 | 2.550M |
| April 05, 2024 | 2.934M |
| April 04, 2024 | 3.093M |
| April 03, 2024 | 1.016M |
| April 02, 2024 | 0.9207M |
| April 01, 2024 | 0.9207M |
| Date | Value |
|---|---|
| March 28, 2024 | 0.0416M |
| March 27, 2024 | 0.3328M |
| March 26, 2024 | 0.3085M |
| March 25, 2024 | 0.357M |
| March 22, 2024 | 0.5512M |
| March 21, 2024 | 0.7938M |
| March 20, 2024 | 0.5997M |
| March 19, 2024 | 0.4056M |
| March 18, 2024 | 0.7938M |
| March 15, 2024 | 0.9394M |
| March 14, 2024 | 1.522M |
| March 13, 2024 | 0.9879M |
| March 12, 2024 | 1.231M |
| March 11, 2024 | 1.012M |
| March 08, 2024 | -0.565M |
| March 07, 2024 | -0.6136M |
| March 06, 2024 | -0.5893M |
| March 05, 2024 | -0.0797M |
| March 04, 2024 | -0.0797M |
| March 01, 2024 | 0.0901M |
| February 29, 2024 | -0.0797M |
| February 28, 2024 | 0.1265M |
| February 27, 2024 | -0.0555M |
| February 26, 2024 | -0.2011M |
| February 23, 2024 | -0.5893M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.541M
Minimum
Dec 28 2022
66.64M
Maximum
Feb 11 2022
7.729M
Average
1.624M
Median
Apr 29 2024
Enterprise Value Benchmarks
| Adaptimmune Therapeutics PLC | 146.78M |
| Biodexa Pharmaceuticals Plc | -2.432M |
| NuCana PLC | -13.49M |
| Autolus Therapeutics PLC | 874.67M |
| Mereo BioPharma Group PLC | 404.26M |
Enterprise Value Related Metrics
| Earnings Yield | -346.3% |
| Normalized Earnings Yield | -3563.42 |